Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Access to healthcare

In the absence of antiretrovirals, people living with HIV opt for herbs

Editor's pick
Key Correspondents
13 October 2011
Access to healthcare

Stavudine, an HIV drug skeleton in India's closet

Editor's pick
Calcutta Telegraph
13 October 2011
Adherence

Copy of Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
Kaiser Daily Global Health Policy Report
13 October 2011
Adherence

Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
AIDSMeds
13 October 2011
Treatment outcomes & life expectancy

'HIV life expectancy rises' in UK

Editor's pick
BBC Health
12 October 2011
People with limited treatment options

HIV Drug Resistance Effect Damped Down over Time

Editor's pick
MedPage Today
10 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
Pharmaceutical industry

Gilead Sciences inks licensing deal for HIV drug -

Editor's pick
Bloomberg BusinessWeek
6 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Global health initiatives

PEPFAR is poised to get on track to end AIDS

Editor's pick
Science Speaks
5 October 2011
New & experimental HIV treatments

Behind the headlines: HIV vaccine passes phase I trial

Editor's pick
NHS Choices
30 September 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
The search for an HIV prevention vaccine

HIV vaccine is a small breakthrough, but not a cure

Editor's pick
The Guardian
29 September 2011
New & experimental HIV treatments

Biotron begins landmark phase 1b/2a human trial for HIV drug

Editor's pick
Business Spectator
29 September 2011
Circumcision

Top economists say circumcision not best anti-HIV tactic

Editor's pick
USA Today
29 September 2011
New & experimental HIV treatments

Off-Label Use of HIV Medications Is Catalyst for More Controversy

Editor's pick
New York Times
24 September 2011
Treatment outcomes & life expectancy

ICAAC: One-Pill HIV Regimen Tied to Less Inpatient Care

Editor's pick
MedPage Today HIV/AIDS
23 September 2011
New & experimental HIV treatments

Edurant® (rilpivirine) receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for use in treatment-naïve adults with HIV-1

Editor's pick
PR Newswire
23 September 2011
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Eviplera(R), a Once-Daily Single Tablet Regimen for the Treatment of HIV Infection

Editor's pick
Market Watch (press release)
23 September 2011
New & experimental HIV treatments

Targeting HIV's sugar coating

Editor's pick
Eurekalert Medicine & Health
23 September 2011
New & experimental HIV treatments

ICAAC: HIV-2 May Yield to Integrase Inhibitor

Editor's pick
MedPage Today HIV/AIDS
22 September 2011
New & experimental HIV treatments

Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

Editor's pick
The Body
21 September 2011
The search for a cure

Scientists find way to "disarm" AIDS virus

Editor's pick
Reuters
20 September 2011
New & experimental HIV treatments

Gilead: Second trial of 4-drug AIDS pill meets goal

Editor's pick
Reuters
19 September 2011